3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
160
Myelodysplastic Syndromes
44
Leukemia, Myelomonocytic, Chronic
25
Leukemia
16
Myeloproliferative Disorders
11
Recurrence
9
Hematologic Neoplasms
8
Neoplasms
6
Lymphoma, T-Cell, Peripheral
6
Primary Myelofibrosis
5
Leukemia, Biphenotypic, Acute
5
Anemia, Refractory, with Excess of Blasts
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasm, Residual
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Monocytic, Acute
4
Hematologic Diseases
4
GATA2 Deficiency
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pathologic Complete Response
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoma
3
Hodgkin Disease
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Polycythemia Vera
2
Lymphoma, T-Cell
2
Interventions
Gemcitabine
11
Cisplatin
10
pembrolizumab
5
Oxaliplatin
4
durvalumab
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Fluorouracil
3
tivozanib
2
Specimen Handling
2
Capecitabine
2
zimberelimab
1
trametinib
1
tislelizumab
1
quemliclustat
1
pertuzumab
1
olaparib
1
irinotecan sucrosofate
1
atezolizumab
1
anlotinib
1
Yttrium-90
1
Tissue Adhesives
1
Tegafur
1
Stents
1
S 1 (combination)
1
Ritonavir
1
Radiosurgery
1
Pancreaticojejunostomy
1
Pancreaticoduodenectomy
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bile Duct Neoplasms
×
Azacitidine
×
1 year
×
Clear all
No trials found.